AAN Press Kits

American Academy of Neurology (AAN) press kits are based on the AAN Annual Meeting, awards, new practice guidelines, and other public efforts from the AAN.

2010 Press Kits

Neuro Film Festival 2011

People who have compelling stories to share regarding how they or a loved one has been affected by a brain disorder are invited to submit a short video to the 2011 Neuro Film Festival, an AAN Foundation event that aims to raise awareness about brain disorders and the need to support research into preventions, treatments and cures. The deadline to enter is February 15, 2011.


New Guideline: MRI Better Than CT Scans at Diagnosing Stroke

Doctors should use a diffusion MRI scan to diagnose stroke instead of a CT scan, according to a new guideline from the American Academy of Neurology.


New Guideline: AAN Guideline on Determining Brain Death Provides More Clarity and Direction

In an effort to create a uniform and accurate method for determining brain death, the American Academy of Neurology has issued an updated guideline that provides doctors with a step-by-step process for determining brain death in adults.


New Guideline: Evaluation and management of driving risk in dementia

The American Academy of Neurology has issued a new guideline to help determine when people with Alzheimer's disease or another type of dementia should stop driving.


New Guideline: Treatment of Nonmotor Symptoms of Parkinson Disease

The American Academy of Neurology has issued a new guideline recommending the most effective treatments to help people with Parkinson's disease who experience sleep, constipation, and sexual problems, which are common but often underrecognized symptoms.


2010 Annual Meeting: E-Press Kits

New Guideline: Symptomatic treatment for muscle cramps

A new guideline from the American Academy of Neurology recommends that the drug quinine, although effective, should be avoided for treatment of routine muscle cramps due to uncommon but serious side effects.

New Guideline: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy

A new guideline from the American Academy of Neurology and the Child Neurology Society finds botulinum toxin type A to be an effective treatment for spasticity, muscle tightness that interferes with movement, in children and adolescents with cerebral palsy, but poses some risk.